DEA schedule
Is dextroamphetamine a controlled substance?
Federal schedule for dextroamphetamine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Dextroamphetamine is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Amphetamine (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted dextroamphetamine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 62 prescription listings from 17 labelers, all Schedule II |
| DEA controlled substances list | Amphetamine: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Amphetamine | 1100 | II | No | Dexedrine; Adderall; Obetrol | Isomer or salt of the listed substance (21 CFR 1308) |
Dextroamphetamine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 64896-674 | DEXEDRINE SPANSULE | capsule, extended release | 10 mg/1 | Amneal Pharmaceuticals LLC | CII |
| 64896-675 | DEXEDRINE SPANSULE | capsule, extended release | 15 mg/1 | Amneal Pharmaceuticals LLC | CII |
| 64896-673 | DEXEDRINE SPANSULE | capsule, extended release | 5 mg/1 | Amneal Pharmaceuticals LLC | CII |
| 68968-0215 | XELSTRYM | patch, extended release | 13.5 mg/1 | Noven Therapeutics, LLC | CII |
| 68968-0220 | XELSTRYM | patch, extended release | 18 mg/1 | Noven Therapeutics, LLC | CII |
| 68968-0205 | XELSTRYM | patch, extended release | 4.5 mg/1 | Noven Therapeutics, LLC | CII |
| 68968-0210 | XELSTRYM | patch, extended release | 9 mg/1 | Noven Therapeutics, LLC | CII |
| 27808-085 | Dextroamphetamine | solution | 5 mg/5mL | Cranbury Pharmaceuticals, LLC | CII |
| 72162-2043 | Dextroamphetamine | solution | 5 mg/5mL | Bryant Ranch Prepack | CII |
| 0115-9928 | Dextroamphetamine Sulfate Extended-Release | capsule, extended release | 10 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0406-8961 | Dextroamphetamine Sulfate Extended-Release | capsule, extended release | 10 mg/1 | SpecGx LLC | CII |
| 45963-304 | dextroamphetamine sulfate | capsule, extended release | 10 mg/1 | Actavis Pharma, Inc. | CII |
| 0115-9929 | Dextroamphetamine Sulfate Extended-Release | capsule, extended release | 15 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0406-8962 | Dextroamphetamine Sulfate Extended-Release | capsule, extended release | 15 mg/1 | SpecGx LLC | CII |
| 45963-305 | dextroamphetamine sulfate | capsule, extended release | 15 mg/1 | Actavis Pharma, Inc. | CII |
| 0115-9927 | Dextroamphetamine Sulfate Extended-Release | capsule, extended release | 5 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0406-8960 | Dextroamphetamine Sulfate Extended-Release | capsule, extended release | 5 mg/1 | SpecGx LLC | CII |
| 45963-303 | dextroamphetamine sulfate | capsule, extended release | 5 mg/1 | Actavis Pharma, Inc. | CII |
| 66993-359 | Dextroamphetamine Sulfate | solution | 5 mg/5mL | Prasco Laboratories | CII |
| 0406-8959 | DEXTROAMPHETAMINE SULFATE | tablet | 10 mg/1 | SpecGx LLC | CII |
| 0555-0953 | Dextroamphetamine Sulfate | tablet | 10 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 10702-066 | Dextroamphetamine Sulfate | tablet | 10 mg/1 | KVK-Tech, Inc. | CII |
| 11534-189 | DEXTROAMPHETAMINE SULFATE | tablet | 10 mg/1 | SUNRISE PHARMACEUTICAL, INC. | CII |
| 13107-036 | DEXTROAMPHETAMINE SULFATE | tablet | 10 mg/1 | Aurolife Pharma, LLC | CII |
| 27808-090 | Dextroamphetamine Sulfate | tablet | 10 mg/1 | Cranbury Pharmaceuticals, LLC | CII |
| 43386-871 | Dextroamphetamine Sulfate | tablet | 10 mg/1 | Lupin Pharmaceuticals,Inc. | CII |
| 52536-510 | Dextroamphetamine Sulfate | tablet | 10 mg/1 | Wilshire Pharmaceuticals, Inc. | CII |
| 63629-2374 | DEXTROAMPHETAMINE SULFATE | tablet | 10 mg/1 | Bryant Ranch Prepack | CII |
| 72162-1234 | DEXTROAMPHETAMINE SULFATE | tablet | 10 mg/1 | Bryant Ranch Prepack | CII |
| 72162-2350 | Dextroamphetamine Sulfate | tablet | 10 mg/1 | Bryant Ranch Prepack | CII |
| 75826-123 | Dextroamphetamine Sulfate | tablet | 10 mg/1 | Winder Laboratories LLC | CII |
| 52536-515 | Dextroamphetamine Sulfate | tablet | 15 mg/1 | Wilshire Pharmaceuticals, Inc. | CII |
| 72162-2351 | Dextroamphetamine Sulfate | tablet | 15 mg/1 | Bryant Ranch Prepack | CII |
| 75826-124 | Dextroamphetamine Sulfate | tablet | 15 mg/1 | Winder Laboratories LLC | CII |
| 75826-120 | Dextroamphetamine Sulfate | tablet | 2.5 mg/1 | Winder Laboratories LLC | CII |
| 52536-520 | Dextroamphetamine Sulfate | tablet | 20 mg/1 | Wilshire Pharmaceuticals, Inc. | CII |
| 72162-2352 | Dextroamphetamine Sulfate | tablet | 20 mg/1 | Bryant Ranch Prepack | CII |
| 75826-125 | Dextroamphetamine Sulfate | tablet | 20 mg/1 | Winder Laboratories LLC | CII |
| 52536-530 | Dextroamphetamine Sulfate | tablet | 30 mg/1 | Wilshire Pharmaceuticals, Inc. | CII |
| 72162-2353 | Dextroamphetamine Sulfate | tablet | 30 mg/1 | Bryant Ranch Prepack | CII |
Showing 40 of 62 listings.
Questions
Is dextroamphetamine a controlled substance?
Yes. Dextroamphetamine is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Amphetamine (Schedule II).
Is dextroamphetamine a narcotic?
No. The DEA list does not mark dextroamphetamine as a narcotic (NARC = N) and places it in Schedule II. Its FDA established pharmacologic class is Central Nervous System Stimulant.
What schedule is dextroamphetamine?
Dextroamphetamine is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Dextroamphetamine
- What is Dextroamphetamine used for?FDA label uses
- Generic for Dexedrine SpansuleFDA Orange Book
- Generic for XelstrymFDA Orange Book
- What is Zenzedi used for?FDA label uses
- Is Zenzedi a controlled substance?Schedule II
- What is Xelstrym used for?FDA label uses
- Is Xelstrym a controlled substance?Schedule II
- What is Dexedrine used for?FDA label uses
- Is Dexedrine a controlled substance?Schedule II
- Central Nervous System Stimulants listFDA drug class
- NDC 64896-673Dextroamphetamine NDC record
- NDC 64896-674Dextroamphetamine NDC record
- NDC 64896-675Dextroamphetamine NDC record
- Schedule II drugs listDEA schedule